The store will not work correctly when cookies are disabled.
4-[(3-Bromobenzyl)thio]thieno[2,3-d]pyrimidine
ID: ALA4776679
PubChem CID: 24368506
Max Phase: Preclinical
Molecular Formula: C13H9BrN2S2
Molecular Weight: 337.27
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: Brc1cccc(CSc2ncnc3sccc23)c1
Standard InChI: InChI=1S/C13H9BrN2S2/c14-10-3-1-2-9(6-10)7-18-13-11-4-5-17-12(11)15-8-16-13/h1-6,8H,7H2
Standard InChI Key: MCYZZTKPRQNPAF-UHFFFAOYSA-N
Molfile:
RDKit 2D
18 20 0 0 0 0 0 0 0 0999 V2000
41.2855 -4.1249 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
41.2842 -4.9523 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.9991 -5.3651 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
41.9973 -3.7122 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.9949 -2.8872 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
41.2791 -2.4768 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.5660 -2.8914 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.8540 -2.4802 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.1413 -2.8942 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.1433 -3.7201 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.8640 -4.1302 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.5738 -3.7139 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.7086 -4.1203 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.7175 -4.9477 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.5071 -5.1949 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
43.9862 -4.5203 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.4926 -3.8563 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.4258 -2.4835 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 14 2 0
13 4 2 0
4 1 1 0
4 5 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 2 0
17 13 1 0
9 18 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 337.27 | Molecular Weight (Monoisotopic): 335.9391 | AlogP: 4.75 | #Rotatable Bonds: 3 |
Polar Surface Area: 25.78 | Molecular Species: NEUTRAL | HBA: 4 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 2 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 1.73 | CX LogP: 4.91 | CX LogD: 4.91 |
Aromatic Rings: 3 | Heavy Atoms: 18 | QED Weighted: 0.51 | Np Likeness Score: -2.67 |
References
1. Rojas-Prats E,Martinez-Gonzalez L,Gonzalo-Consuegra C,Liachko NF,Perez C,Ramírez D,Kraemer BC,Martin-Requero Á,Perez DI,Gil C,de Lago E,Martinez A. (2021) Targeting nuclear protein TDP-43 by cell division cycle kinase 7 inhibitors: A new therapeutic approach for amyotrophic lateral sclerosis., 210 [PMID:33139113] [10.1016/j.ejmech.2020.112968] |